The era of CFTR modulators: improvements made and remaining challenges
- PMID: 33304402
- PMCID: PMC7714553
- DOI: 10.1183/20734735.0016-2020
The era of CFTR modulators: improvements made and remaining challenges
Abstract
The entry into the clinic of CFTR modulators such as TRIKAFTA has significantly improved life for ∼90% CF patients carrying one or two F508del mutations but challenges remain for rare CFTR mutations and the management of lung infections @SaraOcana1 https://bit.ly/3aRafQF.
Copyright ©ERS 2020.
Conflict of interest statement
Conflict of interest: S. Cuevas-Ocaña has nothing to disclose. Conflict of interest: O. Laselva has nothing to disclose. Conflict of interest: J. Avolio has nothing to disclose. Conflict of interest: R. Nenna has nothing to disclose.
References
-
- The Hospital for Sick Children. Cystic fibrosis mutation database. http://genet.sickkids.on.ca/Home.html (2011).
-
- CFF. The Clinical and Functional TRanslation of CFTR (CFTR2). https://cftr2.org/ (2011).
LinkOut - more resources
Full Text Sources